Department of Endodontics, Isfahan (Khorasgan) Branch, I.A.U., Isfahan, Iran.
Department of Cell and Molecular Biology, Cell Science Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, Iran.
Arch Oral Biol. 2018 Sep;93:74-79. doi: 10.1016/j.archoralbio.2018.05.008. Epub 2018 May 19.
This study aimed to compare the behavior of dental pulp stem cells (DPSCs) after isolation using solutions containing either collagenase/dispase or collagenase alone.
DPSCs were isolated by two digestion methods (collagenase/dispase or collagenase alone) from human third molars. Immunophenotypic features were confirmed by flow cytometry for cell markers STRO-1, cluster of differentiation (CD) 146, CD45, and collagen type-I. The proliferation potential of cells was evaluated by 5-bromo-2'-deoxyuridine (brdU) incorporation assay, and finally they were assessed for multi-lineage differentiation potential. Data were analyzed using one-way analysis of variance and independent t-tests.
DPSCs isolated by either method showed similar levels of STRO-1, CD45, and collagen type-I and similar incorporation of brdU (P > 0.05). However, DPSCs obtained by collagenase I/dispase treatment had significantly higher numbers of CD146 cells and osteogenic and chondrogenic capacities compared to those obtained by treatment with collagenase I alone (P < 0.05). On the other hand, more STRO-1+/CD164-DPSCs were found in the collagenase alone group with higher adipogenic potential.
Different enzyme solutions gave rise to different populations of DPSCs. Dispase enhanced isolation of CD146 DPSCs probably by disrupting the basement membranes of blood vessels and releasing DPCSs embedded in the perivascular niche. Furthermore, the differentiation potential of DPSCs was influenced by the change in enzyme solution.
本研究旨在比较使用含有胶原酶/分散酶或单独胶原酶的溶液分离牙髓干细胞(DPSCs)后的行为。
通过两种消化方法(胶原酶/分散酶或单独胶原酶)从人第三磨牙中分离 DPSCs。通过流式细胞术对细胞标志物 STRO-1、分化群(CD)146、CD45 和胶原 I 进行鉴定,以确认免疫表型特征。通过 5-溴-2'-脱氧尿苷(brdU)掺入试验评估细胞的增殖潜力,最后评估其多系分化潜能。使用单因素方差分析和独立 t 检验分析数据。
两种方法分离的 DPSCs 均显示出相似水平的 STRO-1、CD45 和胶原 I,以及相似的 brdU 掺入(P>0.05)。然而,与单独使用胶原酶 I 处理相比,胶原酶 I/分散酶处理获得的 DPSCs 具有更高数量的 CD146 细胞和更强的成骨和成软骨能力(P<0.05)。另一方面,在单独使用胶原酶的组中发现了更多的 STRO-1+/CD164-DPSCs,其具有更高的成脂潜能。
不同的酶溶液产生了不同的 DPSCs 群体。分散酶通过破坏血管基底膜并释放嵌入血管周隙的 DPCs,可能增强了 CD146 DPSCs 的分离。此外,DPSCs 的分化潜能受酶溶液变化的影响。